European Radiology

, Volume 22, Issue 5, pp 1075–1082 | Cite as

Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis: implications for the investigation of the natural history of incidental steatosis

  • Perry J. Pickhardt
  • Seong Ho ParkEmail author
  • Luke Hahn
  • Sung-Gyu Lee
  • Kyongtae T. Bae
  • Eun Sil Yu



To determine a highly specific liver attenuation threshold at unenhanced CT for biopsy-proven moderate to severe hepatic steatosis (≥30% at histology).


315 asymptomatic adults (mean age ± SD, 31.5 ± 10.1 years; 207 men, 108 women) underwent same-day unenhanced liver CT and ultrasound-guided liver biopsy. Blinded to biopsy results, CT liver attenuation was measured using standard region-of-interest methodology. Multiple linear regression analysis was used to assess the relationship of CT liver attenuation with patient age, gender, BMI, CT system, and hepatic fat and iron content.


Thirty-nine subjects had moderate to severe steatosis and 276 had mild or no steatosis. A liver attenuation threshold of 48 HU was 100% specific (276/276) for moderate to severe steatosis, with no false-positives. Sensitivity, PPV and NPV at this HU threshold was 53.8%, 100% and 93.9%. Hepatic fat content was the overwhelming determinant of liver attenuation values, but CT system (P < 0.001), and hepatic iron (P = 0.035) also had a statistically significant independent association.


Unenhanced CT liver attenuation alone is highly specific for moderate to severe hepatic steatosis, allowing for confident non-invasive identification of large retrospective/prospective cohorts for natural history evaluation of incidental non-alcoholic fatty liver disease. Low sensitivity, however, precludes effective population screening at this threshold.

Key Points

Unenhanced CT liver attenuation is highly specific for diagnosing moderate/severe hepatic steatosis.

Unenhanced CT can identify large cohorts for epidemiological studies of incidental steatosis.

Unenhanced CT is not, however, effective for population screening for hepatic steatosis.


Non-alcoholic fatty liver disease (NAFLD) Hepatic steatosis Computed tomography Natural history Non-alcoholic steatohepatitis (NASH) 


  1. 1.
    Boyce CJ, Pickhardt PJ, Kim DH et al (2010) Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT. AJR Am J Roentgenol 194:623–628PubMedCrossRefGoogle Scholar
  2. 2.
    Browning JD, Szczepaniak LS, Dobbins R et al (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40:1387–1395PubMedCrossRefGoogle Scholar
  3. 3.
    Byron D, Minuk GY (1996) Clinical hepatology: profile of an urban, hospital-based practice. Hepatology 24:813–815PubMedCrossRefGoogle Scholar
  4. 4.
    Clark JM, Brancati FL, Diehl AM (2003) The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 98:960–967PubMedCrossRefGoogle Scholar
  5. 5.
    Hilden M, Christoffersen P, Juhl E et al (1977) Liver histology in a ‘normal’ population–examinations of 503 consecutive fatal traffic casualties. Scand J Gastroenterol 12:593–597PubMedCrossRefGoogle Scholar
  6. 6.
    Kammen BF, Pacharn P, Thoeni RF et al (2001) Focal fatty infiltration of the liver: analysis of prevalence and CT findings in children and young adults. AJR Am J Roentgenol 177:1035–1039PubMedGoogle Scholar
  7. 7.
    Park SH, Jeon WK, Kim SH et al (2006) Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol 21:138–143PubMedCrossRefGoogle Scholar
  8. 8.
    Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346:1221–1231PubMedCrossRefGoogle Scholar
  9. 9.
    Dunn W, Xu R, Wingard DL et al (2008) Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 103:2263–2271PubMedCrossRefGoogle Scholar
  10. 10.
    Marchesini G, Bugianesi E, Forlani G et al (2003) Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37:917–923PubMedCrossRefGoogle Scholar
  11. 11.
    Ong JP, Pitts A, Younossi ZM (2008) Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol 49:608–612PubMedCrossRefGoogle Scholar
  12. 12.
    Vuppalanchi R, Chalasani N (2009) Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology 49:306–317PubMedCrossRefGoogle Scholar
  13. 13.
    Brunt EM, Janney CG, Di Bisceglie AM et al (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467–2474PubMedCrossRefGoogle Scholar
  14. 14.
    Hourigan LF, Macdonald GA, Purdie D et al (1999) Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 29:1215–1219PubMedCrossRefGoogle Scholar
  15. 15.
    Kleiner DE, Brunt EM, Van Natta M et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–1321PubMedCrossRefGoogle Scholar
  16. 16.
    Petta S, Camma C, Di Marco V et al (2011) Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. Liver Int 31:507–515PubMedCrossRefGoogle Scholar
  17. 17.
    Selzner M, Clavien PA (2001) Fatty liver in liver transplantation and surgery. Semin Liver Dis 21:105–113PubMedCrossRefGoogle Scholar
  18. 18.
    Angulo P (2010) Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance? Hepatology 51:373–375PubMedCrossRefGoogle Scholar
  19. 19.
    Angulo P (2011) Diagnosing steatohepatitis and predicting liver-related mortality in patients with NAFLD: two distinct concepts. Hepatology 53:1792–1794PubMedCrossRefGoogle Scholar
  20. 20.
    Adams LA, Lymp JF, St Sauver J et al (2005) The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129:113–121PubMedCrossRefGoogle Scholar
  21. 21.
    Dam-Larsen S, Franzmann M, Andersen IB et al (2004) Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut 53:750–755PubMedCrossRefGoogle Scholar
  22. 22.
    Ekstedt M, Franzen LE, Mathiesen UL et al (2006) Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 44:865–873PubMedCrossRefGoogle Scholar
  23. 23.
    Teli MR, James OF, Burt AD, Bennett MK, Day CP (1995) The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 22:1714–1719PubMedCrossRefGoogle Scholar
  24. 24.
    McKimmie RL, Daniel KR, Carr JJ et al (2008) Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study. Am J Gastroenterol 103:3029–3035PubMedCrossRefGoogle Scholar
  25. 25.
    Chalasani N, Wilson L, Kleiner DE et al (2008) Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease. J Hepatol 48:829–834PubMedCrossRefGoogle Scholar
  26. 26.
    Kodama Y, Ng CS, Wu TT et al (2007) Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 188:1307–1312PubMedCrossRefGoogle Scholar
  27. 27.
    Lee SS, Park SH, Kim HJ et al (2010) Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J Hepatol 52:579–585PubMedCrossRefGoogle Scholar
  28. 28.
    Park SH, Kim PN, Kim KW et al (2006) Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 239:105–112PubMedCrossRefGoogle Scholar
  29. 29.
    Park YS, Park SH, Lee SS et al (2011) Biopsy-proven nonsteatotic liver in adults: estimation of reference range for difference in attenuation between the liver and the spleen at nonenhanced CT. Radiology 258:760–766PubMedCrossRefGoogle Scholar
  30. 30.
    Speliotes EK, Massaro JM, Hoffmann U et al (2008) Liver fat is reproducibly measured using computed tomography in the Framingham Heart Study. J Gastroenterol Hepatol 23:894–899PubMedCrossRefGoogle Scholar
  31. 31.
    LeSage GD, Baldus WP, Fairbanks VF et al (1983) Hemochromatosis: genetic or alcohol-induced? Gastroenterology 84:1471–1477PubMedGoogle Scholar
  32. 32.
    Strauss S, Gavish E, Gottlieb P et al (2007) Interobserver and intraobserver variability in the sonographic assessment of fatty liver. AJR Am J Roentgenol 189:W320–323PubMedCrossRefGoogle Scholar
  33. 33.
    Guiu B, Loffroy R, Cercueil JP et al (2008) Multiecho MR imaging and proton MR spectroscopy for liver fat quantification. Radiology 249:1081PubMedCrossRefGoogle Scholar
  34. 34.
    Hines CD, Frydrychowicz A, Hamilton G et al (2011) T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis. J Magn Reson Imaging 33:873–881PubMedCrossRefGoogle Scholar
  35. 35.
    Meisamy S, Hines CD, Hamilton G et al (2011) Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology 258:767–775PubMedCrossRefGoogle Scholar
  36. 36.
    Yokoo T, Bydder M, Hamilton G et al (2009) Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology 251:67–76PubMedCrossRefGoogle Scholar
  37. 37.
    Fischer MA, Gnannt R, Raptis D et al (2011) Quantification of liver fat in the presence of iron and iodine: an ex-vivo dual-energy CT study. Invest Radiol 46:351–358PubMedCrossRefGoogle Scholar
  38. 38.
    Bydder GM, Kreel L, Chapman RW et al (1980) Accuracy of computed tomography in diagnosis of fatty liver. Br Med J 281:1042PubMedCrossRefGoogle Scholar
  39. 39.
    Piekarski J, Goldberg HI, Royal SA et al (1980) Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology 137:727–729PubMedGoogle Scholar
  40. 40.
    Kim DY, Park SH, Lee SS et al (2010) Contrast-enhanced computed tomography for the diagnosis of fatty liver: prospective study with same-day biopsy used as the reference standard. Eur Radiol 20:359–366PubMedCrossRefGoogle Scholar
  41. 41.
    Lee SW, Park SH, Kim KW et al (2007) Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index. Radiology 244:479–485PubMedCrossRefGoogle Scholar
  42. 42.
    Limanond P, Raman SS, Lassman C et al (2004) Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 230:276–280PubMedCrossRefGoogle Scholar
  43. 43.
    Oliva MR, Mortele KJ, Segatto E et al (2005) Computed tomography features of nonalcoholic steatohepatitis with histopathologic correlation. J Comput Assist Tomogr 30:37–43CrossRefGoogle Scholar
  44. 44.
    Yoshimitsu K, Kuroda Y, Nakamuta M et al (2008) Noninvasive estimation of hepatic steatosis using plain CT vs. chemical-shift MR imaging: significance for living donors. J Magn Reson Imaging 28:678–684PubMedCrossRefGoogle Scholar
  45. 45.
    Birnbaum BA, Hindman N, Lee J et al (2007) Multi-detector row CT attenuation measurements: assessment of intra- and interscanner variability with an anthropomorphic body CT phantom. Radiology 242:109–119PubMedCrossRefGoogle Scholar
  46. 46.
    Sande EP, Martinsen AC, Hole EO et al (2010) Interphantom and interscanner variations for Hounsfield units–establishment of reference values for HU in a commercial QA phantom. Phys Med Biol 55:5123–5135PubMedCrossRefGoogle Scholar
  47. 47.
    Cakir B, Kirbas I, Demirhan B et al (2009) Fulminant hepatic failure in children: etiology, histopathology and MDCT findings. Eur J Radiol 72:327–334PubMedCrossRefGoogle Scholar
  48. 48.
    Shakil AO, Jones BC, Lee RG et al (2000) Prognostic value of abdominal CT scanning and hepatic histopathology in patients with acute liver failure. Dig Dis Sci 45:334–339PubMedCrossRefGoogle Scholar
  49. 49.
    Saadeh S, Younossi ZM, Remer EM et al (2002) The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123:745–750PubMedCrossRefGoogle Scholar

Copyright information

© European Society of Radiology 2011

Authors and Affiliations

  • Perry J. Pickhardt
    • 1
  • Seong Ho Park
    • 2
    Email author
  • Luke Hahn
    • 1
  • Sung-Gyu Lee
    • 3
  • Kyongtae T. Bae
    • 5
  • Eun Sil Yu
    • 4
  1. 1.Department of RadiologyUniversity of Wisconsin School of Medicine & Public HealthMadisonUSA
  2. 2.Department of Radiology and Research Institute of RadiologyUniversity of Ulsan College of Medicine, Asan Medical CenterSeoulKorea
  3. 3.Division of Hepatobiliary Surgery and Liver Transplantation, Department of SurgeryUniversity of Ulsan College of Medicine, Asan Medical CenterSeoulKorea
  4. 4.Department of PathologyUniversity of Ulsan College of Medicine, Asan Medical CenterSeoulKorea
  5. 5.Department of RadiologyUniversity of PittsburghPittsburghUSA

Personalised recommendations